Gstm5 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GSTM3 mRNA | CTD | PMID:36331819 |
Gstm5 | Rat | 1,2-dichloroethane | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of GSTM3 mRNA | CTD | PMID:28189721|PMID:28960355 |
Gstm5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of GSTM3 mRNA | CTD | PMID:22206623 |
Gstm5 | Rat | 1,4-dioxane | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | 1,4-dioxane results in increased expression of GSTM3 mRNA | CTD | PMID:33693819 |
Gstm5 | Rat | 1-chloro-2,4-dinitrobenzene | increases metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein polymorphism results in increased metabolism of Dinitrochlorobenzene | CTD | PMID:15247628 |
Gstm5 | Rat | 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Dinitrochlorobenzene results in decreased expression of GSTM3 mRNA | CTD | PMID:21404309 |
Gstm5 | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of GSTM3 protein | CTD | PMID:9794801 |
Gstm5 | Rat | 1-chloro-2,4-dinitrobenzene | affects metabolic processing | EXP | | 6480464 | GSTM3 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:3169012 |
Gstm5 | Rat | 1-chloro-2,4-dinitrobenzene | affects metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:9545290 |
Gstm5 | Rat | 1-chloro-2,4-dinitrobenzene | decreases metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein polymorphism results in decreased metabolism of Dinitrochlorobenzene | CTD | PMID:15247628 |
Gstm5 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GSTM3 mRNA; [1-Naphthylisothiocyanate co-treated with Uric more ... | CTD | PMID:33749747 |
Gstm5 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of GSTM3 mRNA | CTD | PMID:30723492 |
Gstm5 | Rat | 1-naphthyl isothiocyanate | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of GSTM3 mRNA | CTD | PMID:30517764|PMID:33749747 |
Gstm5 | Rat | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:15576828|PMID:15834898|PMID:17557909 |
Gstm5 | Rat | 17alpha-ethynylestradiol | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:17942748 |
Gstm5 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of GSTM3 mRNA | CTD | PMID:17555576 |
Gstm5 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GSTM3 mRNA | CTD | PMID:17942748 |
Gstm5 | Rat | 17beta-estradiol | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of GSTM3 mRNA | CTD | PMID:11331657 |
Gstm5 | Rat | 17beta-estradiol | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:14664709|PMID:39298647 |
Gstm5 | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070|PMID:32145629 |
Gstm5 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA; [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl more ... | CTD | PMID:23457121|PMID:28433925 |
Gstm5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSTM3 mRNA | CTD | PMID:16039398 |
Gstm5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA | CTD | PMID:18172886|PMID:18796159|PMID:19474220|PMID:22496397|PMID:26290441 |
Gstm5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GSTM3 mRNA | CTD | PMID:24680724|PMID:26377647 |
Gstm5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSTM3 mRNA | CTD | PMID:19465110 |
Gstm5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of GSTM3 mRNA; [Tetrachlorodibenzodioxin co-treated more ... | CTD | PMID:16214954|PMID:17942748|PMID:19474220|PMID:22496397|PMID:28433925 |
Gstm5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA | CTD | PMID:21215274 |
Gstm5 | Rat | 2,4,6-tribromophenol | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in increased expression of GSTM3 mRNA | CTD | PMID:31675489 |
Gstm5 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of GSTM3 mRNA | CTD | PMID:38648751 |
Gstm5 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of GSTM3 mRNA | CTD | PMID:21346803 |
Gstm5 | Rat | 2,6-dichloroindophenol | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GSTM3 mRNA | CTD | PMID:21034357 |
Gstm5 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of GSTM3 mRNA | CTD | PMID:21346803 |
Gstm5 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GSTM3 mRNA | CTD | PMID:30851411 |
Gstm5 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTM3 mRNA | CTD | PMID:24378064 |
Gstm5 | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | AHR gene mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTM3 mRNA] | CTD | PMID:34256052 |
Gstm5 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTM3 mRNA | CTD | PMID:34256052 |
Gstm5 | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GSTM3 mRNA | CTD | PMID:23196670 |
Gstm5 | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | Sunphenon promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTM3 mRNA] | CTD | PMID:24378064 |
Gstm5 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of GSTM3 protein | CTD | PMID:31675489 |
Gstm5 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of GSTM3 protein | CTD | PMID:26072098 |
Gstm5 | Rat | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin analog results in decreased expression of GSTM3 protein | CTD | PMID:26597043 |
Gstm5 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 |
Gstm5 | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of GSTM3 mRNA | CTD | PMID:30723492 |
Gstm5 | Rat | 4,4'-sulfonyldiphenol | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | bisphenol S affects the expression of GSTM3 mRNA | CTD | PMID:31683443|PMID:39298647 |
Gstm5 | Rat | 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Oxazolone results in decreased expression of GSTM3 mRNA | CTD | PMID:21404309 |
Gstm5 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Fenretinide results in increased expression of GSTM3 mRNA | CTD | PMID:28973697 |
Gstm5 | Rat | 5-aza-2'-deoxycytidine | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [Decitabine affects the methylation of GSTM3 promoter] which affects the expression of GSTM3 mRNA | CTD | PMID:18664505 |
Gstm5 | Rat | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GSTM3 mRNA | CTD | PMID:33749747 |
Gstm5 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GSTM3 mRNA | CTD | PMID:31881176 |
Gstm5 | Rat | aflatoxin B1 | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of GSTM3 mRNA | CTD | PMID:19770486 |
Gstm5 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GSTM3 mRNA | CTD | PMID:33354967 |
Gstm5 | Rat | all-trans-retinoic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GSTM3 mRNA | CTD | PMID:21934132 |
Gstm5 | Rat | allopurinol | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GSTM3 mRNA | CTD | PMID:33749747 |
Gstm5 | Rat | alpha-Zearalanol | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Zeranol results in increased expression of GSTM3 mRNA | CTD | PMID:11331657 |
Gstm5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GSTM3 mRNA | CTD | PMID:16483693 |
Gstm5 | Rat | amphibole asbestos | affects expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Asbestos, Amphibole affects the expression of GSTM3 protein | CTD | PMID:20855422 |
Gstm5 | Rat | andrographolide | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | andrographolide results in increased expression of GSTM3 mRNA | CTD | PMID:19737545 |
Gstm5 | Rat | andrographolide | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA | CTD | PMID:19737545 |
Gstm5 | Rat | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of GSTM3 mRNA | CTD | PMID:17483316 |
Gstm5 | Rat | aristolochic acid A | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of GSTM3 protein | CTD | PMID:33212167 |
Gstm5 | Rat | aristolochic acids | increases expression | EXP | | 6480464 | Aristolochic Acids results in increased expression of GSTM3 mRNA | CTD | PMID:21834575 |
Gstm5 | Rat | arsane | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Arsenic results in increased expression of GSTM3 mRNA | CTD | PMID:19945496 |
Gstm5 | Rat | arsane | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GSTM3 more ... | CTD | PMID:39836092 |
Gstm5 | Rat | arsane | affects methylation | ISO | GSTM3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of GSTM3 gene | CTD | PMID:25304211 |
Gstm5 | Rat | arsenic atom | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Arsenic results in increased expression of GSTM3 mRNA | CTD | PMID:19945496 |
Gstm5 | Rat | arsenic atom | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GSTM3 more ... | CTD | PMID:39836092 |
Gstm5 | Rat | arsenic atom | affects methylation | ISO | GSTM3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of GSTM3 gene | CTD | PMID:25304211 |
Gstm5 | Rat | arsenite(3-) | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to GSTM3 mRNA] | CTD | PMID:32406909 |
Gstm5 | Rat | arsenous acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GSTM3 mRNA | CTD | PMID:22521957 |
Gstm5 | Rat | asbestos | affects expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Asbestos affects the expression of GSTM3 protein | CTD | PMID:7614465 |
Gstm5 | Rat | atrazine | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
Gstm5 | Rat | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of GSTM3 mRNA | CTD | PMID:28882082 |
Gstm5 | Rat | benzo[a]pyrene | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of GSTM3 protein | CTD | PMID:22138271 |
Gstm5 | Rat | benzo[a]pyrene | decreases methylation | ISO | GSTM3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of GSTM3 promoter | CTD | PMID:27901495 |
Gstm5 | Rat | benzo[a]pyrene | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GSTM3 mRNA | CTD | PMID:21569818|PMID:21964900|PMID:32417428 |
Gstm5 | Rat | benzo[a]pyrene | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSTM3 protein] | CTD | PMID:22138271 |
Gstm5 | Rat | benzo[a]pyrene | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GSTM3 mRNA | CTD | PMID:20064835 |
Gstm5 | Rat | benzyl isothiocyanate | increases expression | EXP | | 6480464 | benzyl isothiocyanate results in increased expression of GSTM3 protein | CTD | PMID:9794803 |
Gstm5 | Rat | beta-naphthoflavone | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA | CTD | PMID:19737545 |
Gstm5 | Rat | beta-naphthoflavone | increases expression | EXP | | 6480464 | beta-Naphthoflavone results in increased expression of GSTM3 protein | CTD | PMID:9794803 |
Gstm5 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased more ... | CTD | PMID:19850644|PMID:28433925 |
Gstm5 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of GSTM3 protein | CTD | PMID:31163220 |
Gstm5 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of GSTM3 mRNA | CTD | PMID:19850644 |
Gstm5 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of GSTM3 mRNA | CTD | PMID:25181051 |
Gstm5 | Rat | bisphenol A | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of GSTM3 mRNA | CTD | PMID:33221593 |
Gstm5 | Rat | bisphenol A | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of GSTM3 protein | CTD | PMID:37567409 |
Gstm5 | Rat | bisphenol A | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased more ... | CTD | PMID:28433925 |
Gstm5 | Rat | bisphenol AF | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of GSTM3 protein | CTD | PMID:34186270 |
Gstm5 | Rat | Bisphenol B | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of GSTM3 protein | CTD | PMID:34186270 |
Gstm5 | Rat | bisphenol F | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 |
Gstm5 | Rat | butanal | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of GSTM3 mRNA | CTD | PMID:26079696 |
Gstm5 | Rat | butylated hydroxyanisole | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Butylated Hydroxyanisole results in increased expression of GSTM3 mRNA; Butylated Hydroxyanisole results in increased expression more ... | CTD | PMID:11991805|PMID:18723825|PMID:6822548 |
Gstm5 | Rat | butylated hydroxyanisole | increases expression | EXP | | 6480464 | Butylated Hydroxyanisole results in increased expression of GSTM3 protein | CTD | PMID:9794803 |
Gstm5 | Rat | cadmium atom | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Cadmium results in increased expression of GSTM3 mRNA | CTD | PMID:24376830 |
Gstm5 | Rat | cadmium dichloride | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of GSTM3 protein | CTD | PMID:24527689 |
Gstm5 | Rat | captan | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Captan results in increased expression of GSTM3 mRNA | CTD | PMID:31558096 |
Gstm5 | Rat | carbon nanotube | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of GSTM3 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681|PMID:25620056 |
Gstm5 | Rat | carbon nanotube | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Nanotubes, Carbon results in decreased expression of GSTM3 protein | CTD | PMID:22157353 |
Gstm5 | Rat | carbon nanotube | affects expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Nanotubes, Carbon affects the expression of GSTM3 protein | CTD | PMID:22001959 |
Gstm5 | Rat | carbonyl cyanide p-trifluoromethoxyphenylhydrazone | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of GSTM3 mRNA | CTD | PMID:16039398 |
Gstm5 | Rat | carmustine | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein results in decreased nitrosation of and results in decreased activity of Carmustine | CTD | PMID:8395980 |
Gstm5 | Rat | carmustine | affects metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein affects the metabolism of Carmustine | CTD | PMID:15247628 |
Gstm5 | Rat | carmustine | decreases nitrosation | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein results in decreased nitrosation of Carmustine | CTD | PMID:11841793 |
Gstm5 | Rat | CGP 52608 | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GSTM3 gene] | CTD | PMID:28238834 |
Gstm5 | Rat | chloroform | decreases expression | EXP | | 6480464 | Chloroform results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | chloroprene | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Chloroprene results in increased expression of GSTM3 mRNA | CTD | PMID:23125180 |
Gstm5 | Rat | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of GSTM3 mRNA | CTD | PMID:17452286 |
Gstm5 | Rat | chlorpyrifos | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Chlorpyrifos results in decreased expression of GSTM3 mRNA | CTD | PMID:33011216 |
Gstm5 | Rat | chlorpyrifos | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
Gstm5 | Rat | cholic acid | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Cholic Acid results in increased expression of GSTM3 mRNA | CTD | PMID:17521389 |
Gstm5 | Rat | choline | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 |
Gstm5 | Rat | cisplatin | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GSTM3 mRNA | CTD | PMID:27594783 |
Gstm5 | Rat | cisplatin | affects response to substance | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 gene polymorphism affects the susceptibility to Cisplatin; GSTM3 protein affects the susceptibility to Cisplatin | CTD | PMID:11081456|PMID:16217747 |
Gstm5 | Rat | clofibrate | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Clofibrate results in increased expression of GSTM3 mRNA | CTD | PMID:22496397 |
Gstm5 | Rat | clofibrate | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [Clofibrate results in increased expression of GSTM3 mRNA] | CTD | PMID:22496397 |
Gstm5 | Rat | clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of GSTM3 mRNA | CTD | PMID:17602206 |
Gstm5 | Rat | cobalt atom | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Cobalt results in increased expression of GSTM3 mRNA | CTD | PMID:22147119 |
Gstm5 | Rat | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA; [Copper more ... | CTD | PMID:20302851 |
Gstm5 | Rat | copper atom | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of GSTM3 mRNA | CTD | PMID:30911355 |
Gstm5 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of GSTM3 mRNA | CTD | PMID:30556269 |
Gstm5 | Rat | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA; [Copper more ... | CTD | PMID:20302851 |
Gstm5 | Rat | copper(0) | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of GSTM3 mRNA | CTD | PMID:30911355 |
Gstm5 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of GSTM3 mRNA | CTD | PMID:30556269 |
Gstm5 | Rat | coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of GSTM3 protein | CTD | PMID:9794803 |
Gstm5 | Rat | coumarin | decreases phosphorylation | ISO | GSTM3 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of GSTM3 protein | CTD | PMID:35688186 |
Gstm5 | Rat | cumene hydroperoxide | increases metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein polymorphism results in increased metabolism of cumene hydroperoxide | CTD | PMID:15247628 |
Gstm5 | Rat | cumene hydroperoxide | decreases metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein polymorphism results in decreased metabolism of cumene hydroperoxide | CTD | PMID:15247628 |
Gstm5 | Rat | cyanocob(III)alamin | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 |
Gstm5 | Rat | cyclosporin A | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of GSTM3 mRNA | CTD | PMID:19770486 |
Gstm5 | Rat | cyclosporin A | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GSTM3 mRNA | CTD | PMID:25562108|PMID:27989131 |
Gstm5 | Rat | cylindrospermopsin | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of GSTM3 mRNA | CTD | PMID:23726867 |
Gstm5 | Rat | cyproconazole | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | cyproconazole results in increased expression of GSTM3 mRNA | CTD | PMID:22334560|PMID:23970803 |
Gstm5 | Rat | D-penicillamine | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Penicillamine results in increased expression of GSTM3 mRNA | CTD | PMID:22843330 |
Gstm5 | Rat | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | dexamethasone | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 |
Gstm5 | Rat | dexamethasone | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 |
Gstm5 | Rat | dextran sulfate | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GSTM3 protein]; evodiamine inhibits more ... | CTD | PMID:32272095|PMID:35362542 |
Gstm5 | Rat | dextran sulfate | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of GSTM3 protein | CTD | PMID:35362542 |
Gstm5 | Rat | dextran sulfate | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of GSTM3 protein | CTD | PMID:32272095 |
Gstm5 | Rat | Diallyl sulfide | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | allyl sulfide results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 |
Gstm5 | Rat | diarsenic trioxide | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GSTM3 mRNA | CTD | PMID:22521957 |
Gstm5 | Rat | diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of GSTM3 mRNA | CTD | PMID:17452286|PMID:19440498 |
Gstm5 | Rat | diazinon | increases methylation | ISO | GSTM3 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of GSTM3 gene | CTD | PMID:22964155 |
Gstm5 | Rat | dibenzofurans | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Dibenzofurans results in increased expression of GSTM3 mRNA | CTD | PMID:34254344 |
Gstm5 | Rat | dibenzoylmethane | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [sulforaphane co-treated with dibenzoylmethane] results in increased expression of GSTM3 mRNA | CTD | PMID:17942926 |
Gstm5 | Rat | dibenzoylmethane | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | dibenzoylmethane results in increased expression of GSTM3 mRNA | CTD | PMID:17942926 |
Gstm5 | Rat | dichloroacetic acid | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of GSTM3 mRNA | CTD | PMID:28962523 |
Gstm5 | Rat | diclofenac | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Diclofenac results in increased expression of GSTM3 mRNA | CTD | PMID:26934552 |
Gstm5 | Rat | dicrotophos | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of GSTM3 mRNA | CTD | PMID:28302478 |
Gstm5 | Rat | dicyclanil | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | dicyclanil results in increased expression of GSTM3 mRNA | CTD | PMID:15664270 |
Gstm5 | Rat | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of GSTM3 mRNA | CTD | PMID:19440498 |
Gstm5 | Rat | diethylstilbestrol | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of GSTM3 mRNA | CTD | PMID:11331657 |
Gstm5 | Rat | dimethylarsinous acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | dimethylarsinous acid results in increased expression of GSTM3 mRNA | CTD | PMID:20886546 |
Gstm5 | Rat | dinophysistoxin 1 | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | dinophysistoxin 1 results in increased expression of GSTM3 mRNA | CTD | PMID:28939011 |
Gstm5 | Rat | diquat | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Diquat results in increased expression of GSTM3 mRNA | CTD | PMID:36851058 |
Gstm5 | Rat | disodium selenite | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of GSTM3 mRNA | CTD | PMID:24383545 |
Gstm5 | Rat | doramapimod | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | doramapimod results in increased expression of GSTM3 mRNA | CTD | PMID:21328587 |
Gstm5 | Rat | dorsomorphin | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Gstm5 | Rat | doxorubicin | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of GSTM3 mRNA | CTD | PMID:26873546 |
Gstm5 | Rat | doxorubicin | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of GSTM3 mRNA | CTD | PMID:29803840 |
Gstm5 | Rat | doxorubicin | increases oxidation | EXP | | 6480464 | Doxorubicin results in increased oxidation of GSTM3 protein | CTD | PMID:28818578 |
Gstm5 | Rat | emodin | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Emodin results in decreased expression of GSTM3 mRNA | CTD | PMID:16045814 |
Gstm5 | Rat | endosulfan | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Endosulfan results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
Gstm5 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of GSTM3 mRNA | CTD | PMID:29391264 |
Gstm5 | Rat | endosulfan | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
Gstm5 | Rat | enzyme inhibitor | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 |
Gstm5 | Rat | epoxiconazole | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of GSTM3 mRNA | CTD | PMID:22334560|PMID:23970803 |
Gstm5 | Rat | epoxiconazole | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of GSTM3 mRNA | CTD | PMID:35436446 |
Gstm5 | Rat | erianin | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GSTM3 protein] | CTD | PMID:32272095 |
Gstm5 | Rat | erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of GSTM3 mRNA | CTD | PMID:16098508 |
Gstm5 | Rat | ethanol | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Ethanol results in increased expression of GSTM3 mRNA | CTD | PMID:19167417 |
Gstm5 | Rat | ethoxyquin | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Ethoxyquin results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 |
Gstm5 | Rat | ethoxyquin | increases expression | EXP | | 6480464 | Ethoxyquin results in increased expression of GSTM3 protein | CTD | PMID:9794803 |
Gstm5 | Rat | Evodiamine | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GSTM3 protein] | CTD | PMID:35362542 |
Gstm5 | Rat | fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA | CTD | PMID:18253720|PMID:18775883 |
Gstm5 | Rat | fenofibrate | decreases expression | EXP | | 6480464 | Fenofibrate results in decreased expression of GSTM3 mRNA | CTD | PMID:18775883 |
Gstm5 | Rat | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of GSTM3 mRNA | CTD | PMID:18035473 |
Gstm5 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of GSTM3 mRNA | CTD | PMID:24136188 |
Gstm5 | Rat | folic acid | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 |
Gstm5 | Rat | folpet | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | folpet results in increased expression of GSTM3 mRNA | CTD | PMID:31558096 |
Gstm5 | Rat | fumonisin B1 | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | fumonisin B1 results in increased expression of GSTM3 mRNA | CTD | PMID:16221962 |
Gstm5 | Rat | furan | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | furan results in increased expression of GSTM3 mRNA | CTD | PMID:20194422 |
Gstm5 | Rat | gliclazide | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] | CTD | PMID:21439372 |
Gstm5 | Rat | glutathione | affects metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein affects the metabolism of Glutathione | CTD | PMID:9545290 |
Gstm5 | Rat | glycine betaine | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 |
Gstm5 | Rat | glyphosate | affects expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Glyphosate affects the expression of GSTM3 protein | CTD | PMID:37047296 |
Gstm5 | Rat | glyphosate | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Glyphosate results in increased expression of GSTM3 mRNA | CTD | PMID:37047296 |
Gstm5 | Rat | graphite | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Graphite results in decreased expression of GSTM3 protein | CTD | PMID:22157353 |
Gstm5 | Rat | GW 4064 | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | GW 4064 results in increased expression of GSTM3 mRNA | CTD | PMID:26655953 |
Gstm5 | Rat | homocysteine | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [Methionine deficiency co-treated with Homocysteine] affects the expression of GSTM3 protein | CTD | PMID:17116298 |
Gstm5 | Rat | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA; [indole-3-carbinol co-treated with Phenobarbital] more ... | CTD | PMID:22129741|PMID:24418717 |
Gstm5 | Rat | indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol results in increased expression of GSTM3 mRNA; indole-3-carbinol results in increased expression of GSTM3 more ... | CTD | PMID:24418717|PMID:9794803 |
Gstm5 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of GSTM3 mRNA | CTD | PMID:21396975 |
Gstm5 | Rat | indometacin | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 |
Gstm5 | Rat | inulin | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GSTM3 mRNA | CTD | PMID:36331819 |
Gstm5 | Rat | iron atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA | CTD | PMID:20302851 |
Gstm5 | Rat | iron(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA | CTD | PMID:20302851 |
Gstm5 | Rat | ivermectin | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of GSTM3 protein | CTD | PMID:32959892 |
Gstm5 | Rat | kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA; more ... | CTD | PMID:18544905 |
Gstm5 | Rat | kojic acid | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA | CTD | PMID:17917374 |
Gstm5 | Rat | L-methionine | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [Methionine deficiency co-treated with Homocysteine] affects the expression of GSTM3 protein; Methionine inhibits the reaction more ... | CTD | PMID:17116298|PMID:22138271 |
Gstm5 | Rat | L-methionine | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 |
Gstm5 | Rat | lipopolysaccharide | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of GSTM3 mRNA | CTD | PMID:27339419 |
Gstm5 | Rat | lipopolysaccharide | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GSTM3 mRNA | CTD | PMID:35811015 |
Gstm5 | Rat | lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of GSTM3 mRNA | CTD | PMID:18082333 |
Gstm5 | Rat | lithium chloride | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Lithium Chloride results in increased activity of CTNNB1 protein] which results in increased expression of more ... | CTD | PMID:20118494 |
Gstm5 | Rat | lithium hydride | increases expression | EXP | | 6480464 | Lithium results in increased expression of GSTM3 mRNA | CTD | PMID:18082333 |
Gstm5 | Rat | medroxyprogesterone acetate | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Medroxyprogesterone Acetate results in increased expression of GSTM3 mRNA | CTD | PMID:18497975 |
Gstm5 | Rat | mefenamic acid | increases glutathionylation | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein results in increased glutathionylation of Mefenamic Acid analog | CTD | PMID:25372302 |
Gstm5 | Rat | microcystin | affects expression | EXP | | 6480464 | Microcystins affects the expression of GSTM3 mRNA | CTD | PMID:19790251 |
Gstm5 | Rat | microcystin | decreases expression | EXP | | 6480464 | Microcystins results in decreased expression of GSTM3 mRNA | CTD | PMID:19790251 |
Gstm5 | Rat | microcystin-LR | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of GSTM3 mRNA | CTD | PMID:17654400 |
Gstm5 | Rat | microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of GSTM3 mRNA | CTD | PMID:34740672 |
Gstm5 | Rat | monocrotaline | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of more ... | CTD | PMID:21224054 |
Gstm5 | Rat | monosodium L-glutamate | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of GSTM3 mRNA | CTD | PMID:19001666|PMID:25473020 |
Gstm5 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GSTM3 mRNA | CTD | PMID:20061341 |
Gstm5 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA; [Diethylnitrosamine co-treated with kojic more ... | CTD | PMID:17917374|PMID:23457121|PMID:24535843 |
Gstm5 | Rat | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of GSTM3 mRNA | CTD | PMID:14965361 |
Gstm5 | Rat | N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of GSTM3 mRNA | CTD | PMID:19638242 |
Gstm5 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA; [Copper more ... | CTD | PMID:18253720|PMID:18544905|PMID:18775883|PMID:20302851|PMID:22129741|PMID:23665939|PMID:28943392 |
Gstm5 | Rat | naloxone | decreases expression | EXP | | 6480464 | Naloxone results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | naphthalene | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | naphthalene affects the expression of GSTM3 mRNA | CTD | PMID:31020322 |
Gstm5 | Rat | nickel atom | affects expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Nickel affects the expression of GSTM3 mRNA | CTD | PMID:14575637 |
Gstm5 | Rat | nickel atom | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of GSTM3 mRNA | CTD | PMID:24768652|PMID:25583101 |
Gstm5 | Rat | nickel atom | affects expression | EXP | | 6480464 | Nickel affects the expression of GSTM3 mRNA | CTD | PMID:19440498 |
Gstm5 | Rat | nickel atom | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of GSTM3 mRNA] | CTD | PMID:14575637 |
Gstm5 | Rat | nicotinamide | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA; Gliclazide inhibits the reaction more ... | CTD | PMID:21439372 |
Gstm5 | Rat | non-2-enal | increases metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein polymorphism results in increased metabolism of 2-nonenal | CTD | PMID:15247628 |
Gstm5 | Rat | non-2-enal | decreases metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein polymorphism results in decreased metabolism of 2-nonenal | CTD | PMID:15247628 |
Gstm5 | Rat | ochratoxin A | increases acetylation | ISO | GSTM3 (Homo sapiens) | 6480464 | ochratoxin A results in increased acetylation of GSTM3 promoter | CTD | PMID:29098329 |
Gstm5 | Rat | ochratoxin A | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of GSTM3 mRNA | CTD | PMID:32905824 |
Gstm5 | Rat | ochratoxin A | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [ochratoxin A results in increased acetylation of GSTM3 promoter] which results in increased expression of more ... | CTD | PMID:29098329 |
Gstm5 | Rat | ochratoxin A | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | ochratoxin A results in increased expression of GSTM3 mRNA | CTD | PMID:29098329 |
Gstm5 | Rat | okadaic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of GSTM3 mRNA | CTD | PMID:28939011|PMID:38832940 |
Gstm5 | Rat | oltipraz | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | oltipraz results in increased expression of GSTM3 mRNA | CTD | PMID:18723825|PMID:22496397 |
Gstm5 | Rat | oltipraz | increases expression | EXP | | 6480464 | oltipraz results in increased expression of GSTM3 protein | CTD | PMID:9794803 |
Gstm5 | Rat | oltipraz | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTM3 more ... | CTD | PMID:22496397 |
Gstm5 | Rat | orphenadrine | multiple interactions | EXP | | 6480464 | [Orphenadrine co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA; [Phenobarbital co-treated with Orphenadrine] more ... | CTD | PMID:23665939|PMID:23665940 |
Gstm5 | Rat | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of GSTM3 mRNA | CTD | PMID:23665940 |
Gstm5 | Rat | ozone | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Ozone results in decreased expression of GSTM3 mRNA | CTD | PMID:12763052 |
Gstm5 | Rat | ozone | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Ozone results in increased expression of GSTM3 mRNA | CTD | PMID:23033980 |
Gstm5 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | paracetamol | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of GSTM3 mRNA | CTD | PMID:16611625 |
Gstm5 | Rat | paraquat | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Paraquat results in increased expression of GSTM3 mRNA | CTD | PMID:20883675 |
Gstm5 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of GSTM3 mRNA | CTD | PMID:32680482 |
Gstm5 | Rat | paraquat | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Paraquat results in increased expression of GSTM3 mRNA | CTD | PMID:16128001 |
Gstm5 | Rat | pentachlorophenol | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of GSTM3 mRNA | CTD | PMID:23892564 |
Gstm5 | Rat | pentanal | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | pentanal results in increased expression of GSTM3 mRNA | CTD | PMID:26079696 |
Gstm5 | Rat | perfluorodecanoic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | perfluorodecanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:35337807 |
Gstm5 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of GSTM3 mRNA | CTD | PMID:28558994 |
Gstm5 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in increased expression of GSTM3 mRNA | CTD | PMID:35337807 |
Gstm5 | Rat | perfluorononanoic acid | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:28558994 |
Gstm5 | Rat | perfluorononanoic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:35337807 |
Gstm5 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of GSTM3 mRNA; [perfluorooctane more ... | CTD | PMID:25949234|PMID:32979393|PMID:32991729|PMID:33483757|PMID:36331819 |
Gstm5 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of GSTM3 mRNA | CTD | PMID:35337807 |
Gstm5 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of GSTM3 mRNA | CTD | PMID:26300304 |
Gstm5 | Rat | perfluorooctane-1-sulfonic acid | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid affects the expression of GSTM3 mRNA | CTD | PMID:19429403 |
Gstm5 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of GSTM3 mRNA | CTD | PMID:20936131|PMID:25949234|PMID:32979393 |
Gstm5 | Rat | perfluorooctanesulfonamide | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | perfluorooctanesulfonamide analog results in increased expression of GSTM3 mRNA | CTD | PMID:35337807 |
Gstm5 | Rat | perfluorooctanoic acid | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [NR1H3 gene mutant form results in increased susceptibility to perfluorooctanoic acid] which results in increased more ... | CTD | PMID:18281256|PMID:23626681|PMID:25949234 |
Gstm5 | Rat | perfluorooctanoic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:35337807 |
Gstm5 | Rat | perfluorooctanoic acid | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:18281256|PMID:20118188|PMID:28558994|PMID:30711707|PMID:32822737|PMID:37422089 |
Gstm5 | Rat | perfluorooctanoic acid | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | perfluorooctanoic acid affects the expression of GSTM3 mRNA | CTD | PMID:18281256|PMID:19429403 |
Gstm5 | Rat | perfluoroundecanoic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | perfluoroundecanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:35337807 |
Gstm5 | Rat | permethrin | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Permethrin results in increased expression of GSTM3 mRNA | CTD | PMID:30629241 |
Gstm5 | Rat | phenanthrene | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of GSTM3 mRNA] | CTD | PMID:31181217 |
Gstm5 | Rat | phenanthrene | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | phenanthrene results in increased expression of GSTM3 mRNA | CTD | PMID:31181217 |
Gstm5 | Rat | phenobarbital | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA; [Methionine co-treated with Choline more ... | CTD | PMID:19482888|PMID:20118494|PMID:24535843|PMID:33549593 |
Gstm5 | Rat | phenobarbital | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA; Phenobarbital results in increased expression of GSTM3 more ... | CTD | PMID:18723825|PMID:19270015|PMID:19482888|PMID:20118494|PMID:20403969|PMID:21335049|PMID:23091169|PMID:28541575|PMID:30629241|PMID:33549593 |
Gstm5 | Rat | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA; Phenobarbital results in increased expression of GSTM3 more ... | CTD | PMID:24418717|PMID:9794803 |
Gstm5 | Rat | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of GSTM3 mRNA | CTD | PMID:23665940|PMID:24025784 |
Gstm5 | Rat | phenobarbital | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA; [Phenobarbital co-treated with Orphenadrine] more ... | CTD | PMID:23665940|PMID:24025784|PMID:24418717 |
Gstm5 | Rat | phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of GSTM3 mRNA | CTD | PMID:18158353 |
Gstm5 | Rat | phenytoin | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of more ... | CTD | PMID:21224054 |
Gstm5 | Rat | picoxystrobin | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | picoxystrobin results in increased expression of GSTM3 mRNA | CTD | PMID:33512557 |
Gstm5 | Rat | piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of GSTM3 mRNA | CTD | PMID:18544911|PMID:22484513 |
Gstm5 | Rat | piperonyl butoxide | multiple interactions | EXP | | 6480464 | Piperonyl Butoxide affects the reaction [Phenobarbital affects the expression of GSTM3 mRNA] | CTD | PMID:24025784 |
Gstm5 | Rat | pirinixic acid | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GSTM3 mRNA | CTD | PMID:16221962|PMID:17426115 |
Gstm5 | Rat | pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Pregnenolone Carbonitrile results in increased activity of NR1I2 protein] which results in increased expression of more ... | CTD | PMID:22496397 |
Gstm5 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of GSTM3 mRNA | CTD | PMID:18723825|PMID:22496397|PMID:27413110|PMID:28903501 |
Gstm5 | Rat | propanal | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of GSTM3 mRNA | CTD | PMID:26079696 |
Gstm5 | Rat | propiconazole | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | NR1H3 gene mutant form promotes the reaction [propiconazole results in increased expression of GSTM3 mRNA] | CTD | PMID:25949234 |
Gstm5 | Rat | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of GSTM3 mRNA | CTD | PMID:16643972 |
Gstm5 | Rat | propiconazole | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | propiconazole results in increased expression of GSTM3 mRNA | CTD | PMID:21278054|PMID:22334560|PMID:23970803|PMID:25949234 |
Gstm5 | Rat | prostaglandin E2 | affects chemical synthesis | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein affects the chemical synthesis of Dinoprostone | CTD | PMID:10905636 |
Gstm5 | Rat | prostaglandin H2 | affects metabolic processing | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein affects the metabolism of Prostaglandin H2 | CTD | PMID:10905636 |
Gstm5 | Rat | prostaglandins E | affects chemical synthesis | ISO | GSTM3 (Homo sapiens) | 6480464 | GSTM3 protein affects the chemical synthesis of Prostaglandins E | CTD | PMID:10905636 |
Gstm5 | Rat | pyrene | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | pyrene results in increased expression of GSTM3 mRNA | CTD | PMID:26160115 |
Gstm5 | Rat | quercetin | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Quercetin results in decreased expression of GSTM3 mRNA | CTD | PMID:16455785 |
Gstm5 | Rat | quinidine | decreases expression | EXP | | 6480464 | Quinidine results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | rac-lactic acid | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GSTM3 mRNA | CTD | PMID:30851411 |
Gstm5 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] | CTD | PMID:21439372 |
Gstm5 | Rat | rifampicin | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of more ... | CTD | PMID:21224054 |
Gstm5 | Rat | ritodrine | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Ritodrine results in increased expression of GSTM3 mRNA | CTD | PMID:23370008 |
Gstm5 | Rat | rotenone | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Rotenone results in increased expression of GSTM3 mRNA | CTD | PMID:33512557 |
Gstm5 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine results in increased expression of GSTM3 mRNA | CTD | PMID:35811015 |
Gstm5 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GSTM3 mRNA | CTD | PMID:35811015 |
Gstm5 | Rat | SB 431542 | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GSTM3 more ... | CTD | PMID:27188386|PMID:37664457 |
Gstm5 | Rat | silicon dioxide | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of GSTM3 mRNA | CTD | PMID:25895662 |
Gstm5 | Rat | sodium arsenite | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GSTM3 mRNA | CTD | PMID:20886546|PMID:29301061|PMID:38568856 |
Gstm5 | Rat | sodium arsenite | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of GSTM3 mRNA | CTD | PMID:37682722 |
Gstm5 | Rat | sodium arsenite | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GSTM3 more ... | CTD | PMID:39836092 |
Gstm5 | Rat | sodium arsenite | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of GSTM3 mRNA | CTD | PMID:34032870 |
Gstm5 | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of GSTM3 protein | CTD | PMID:29459688 |
Gstm5 | Rat | sodium arsenite | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | sodium arsenite affects the expression of GSTM3 mRNA | CTD | PMID:16507464 |
Gstm5 | Rat | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of GSTM3 mRNA | CTD | PMID:19281266 |
Gstm5 | Rat | spironolactone | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Spironolactone results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 |
Gstm5 | Rat | stilbene oxide | increases expression | EXP | | 6480464 | stilbene oxide results in increased expression of GSTM3 protein | CTD | PMID:9794803 |
Gstm5 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA; Gliclazide inhibits the reaction more ... | CTD | PMID:21439372 |
Gstm5 | Rat | sulfasalazine | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Sulfasalazine results in increased expression of GSTM3 mRNA | CTD | PMID:31830553 |
Gstm5 | Rat | sulforaphane | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | sulforaphane results in increased expression of GSTM3 mRNA | CTD | PMID:17942926 |
Gstm5 | Rat | sulforaphane | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [sulforaphane co-treated with dibenzoylmethane] results in increased expression of GSTM3 mRNA | CTD | PMID:17942926 |
Gstm5 | Rat | sunitinib | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of GSTM3 mRNA | CTD | PMID:31533062 |
Gstm5 | Rat | tamoxifen | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | Tamoxifen affects the expression of GSTM3 mRNA | CTD | PMID:17555576 |
Gstm5 | Rat | tauroursodeoxycholic acid | decreases expression | EXP | | 6480464 | ursodoxicoltaurine results in decreased expression of GSTM3 mRNA | CTD | PMID:15885361 |
Gstm5 | Rat | temozolomide | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of GSTM3 mRNA | CTD | PMID:31758290 |
Gstm5 | Rat | tetrachloromethane | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of GSTM3 mRNA | CTD | PMID:27339419|PMID:29987408 |
Gstm5 | Rat | tetrachloromethane | affects expression | ISO | Gstm5 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of GSTM3 mRNA | CTD | PMID:31919559 |
Gstm5 | Rat | tetrachloromethane | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of GSTM3 more ... | CTD | PMID:16006527 |
Gstm5 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of GSTM3 mRNA | CTD | PMID:16239168 |
Gstm5 | Rat | tetracycline | decreases activity | ISO | GSTM3 (Homo sapiens) | 6480464 | Tetracycline results in decreased activity of GSTM3 protein | CTD | PMID:11807801 |
Gstm5 | Rat | tetracycline | decreases expression | EXP | | 6480464 | Tetracycline results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | theophylline | decreases expression | EXP | | 6480464 | Theophylline results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
Gstm5 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GSTM3 mRNA | CTD | PMID:23411599|PMID:34492290 |
Gstm5 | Rat | thioacetamide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GSTM3 mRNA | CTD | PMID:28943392 |
Gstm5 | Rat | titanium dioxide | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of GSTM3 mRNA | CTD | PMID:23557971 |
Gstm5 | Rat | titanium dioxide | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of GSTM3 mRNA | CTD | PMID:35295148 |
Gstm5 | Rat | toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of GSTM3 mRNA | CTD | PMID:18653662 |
Gstm5 | Rat | toluene 2,4-diisocyanate | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Toluene 2,4-Diisocyanate results in decreased expression of GSTM3 mRNA | CTD | PMID:21404309 |
Gstm5 | Rat | triadimefon | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | NR1H3 gene mutant form promotes the reaction [triadimefon results in increased expression of GSTM3 mRNA] | CTD | PMID:25949234 |
Gstm5 | Rat | triadimefon | increases expression | EXP | | 6480464 | triadimefon results in increased expression of GSTM3 mRNA | CTD | PMID:16643972 |
Gstm5 | Rat | triadimefon | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | triadimefon results in increased expression of GSTM3 mRNA | CTD | PMID:23970803|PMID:25949234 |
Gstm5 | Rat | trichloroethene | increases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of GSTM3 mRNA | CTD | PMID:25549359 |
Gstm5 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of GSTM3 mRNA | CTD | PMID:33387578 |
Gstm5 | Rat | trichostatin A | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of GSTM3 mRNA] | CTD | PMID:14575637 |
Gstm5 | Rat | trichostatin A | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GSTM3 mRNA | CTD | PMID:24935251 |
Gstm5 | Rat | trimellitic anhydride | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of GSTM3 mRNA | CTD | PMID:19042947 |
Gstm5 | Rat | troglitazone | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | troglitazone results in increased expression of GSTM3 mRNA | CTD | PMID:19631733 |
Gstm5 | Rat | troglitazone | decreases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | troglitazone results in decreased expression of GSTM3 mRNA | CTD | PMID:19631733 |
Gstm5 | Rat | tunicamycin | decreases expression | ISO | Gstm5 (Mus musculus) | 6480464 | Tunicamycin results in decreased expression of GSTM3 mRNA | CTD | PMID:17127020 |
Gstm5 | Rat | ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of GSTM3 mRNA | CTD | PMID:15885361 |
Gstm5 | Rat | valproic acid | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GSTM3 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509 |
Gstm5 | Rat | valproic acid | multiple interactions | ISO | GSTM3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 |
Gstm5 | Rat | zinc atom | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 |
Gstm5 | Rat | zinc pyrithione | increases expression | ISO | GSTM3 (Homo sapiens) | 6480464 | pyrithione zinc results in increased expression of GSTM3 mRNA | CTD | PMID:21424779 |
Gstm5 | Rat | zinc(0) | multiple interactions | ISO | Gstm5 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 |